Pfizer backs bill seeking FDA review of drug ads

The head of one of the world's largest pharmaceutical companies says it would agree to submit all advertising for advance review by the Food and Drug Administration, one of the aims of a disputed measure before Congress. But Pfizer Inc. chairman Hank McKinnell also criticized congressional efforts he said could overemphasize drug risks. (Full article: 603 words)

This article is available in our archives:

Globe Subscribers

FREE for subscribers

Subscribers to the Boston Globe get unlimited access to our archives.

Not a subscriber?

Non-Subscribers

Purchase an electronic copy of the full article. Learn More

• $4.95 1 article
• $9.95 4 articles
• $25.95 Monthly